DNA Damage/DNA Repair
Research Areas
- MTH1(4)
- PARP(103)
- ATM/ATR(31)
- DNA Alkylating(23)
- DNA Ligases(3)
- DNA Methyltransferase(27)
- DNA-PK(28)
- HDAC(143)
- Nucleoside Antimetabolite/Analogue(194)
- Telomerase(15)
- Topoisomerase(193)
- tankyrase(5)
- Antifolate(33)
- CDK(299)
- Checkpoint Kinase (Chk)(36)
- CRISPR/Cas9(9)
- Deubiquitinase(84)
- DNA Alkylator/Crosslinker(87)
- DNA/RNA Synthesis(575)
- Eukaryotic Initiation Factor (eIF)(33)
- IRE1(25)
- LIM Kinase (LIMK)(12)
- TOPK(6)
- Casein Kinase(59)
- DNA Intercalating Agents(8)
- DNA/RNA Oxidative Damage(13)
- Poly(ADP-ribose) Glycohydrolase (PARG)(5)
- Early 2 Factor (E2F)(2)
- Zinc Finger Protein(1)
Products Related to DNA Damage/DNA Repair(1968)
- GC79176ARUK2010489Purity: >96.50%
ARUK2010489 (Compound 23) is a potent, selective and brain-penetrant NUAK1 inhibitor with a pIC 50 of 8.7.
- GC79370PD-L1/HDAC6-IN-1 TFAPurity: >99.50%
PD-L1/HDAC6-IN-1 TFA is an orally active dual inhibitor of PD-L1 and HDAC6, with IC 50 values of 26.8 nM and 78 nM, respectively.
- GC79488QBS10072S dihydrochlorideCAS: 1802735-31-4Purity: >98%
QBS10072S dihydrochloride is a LAT1 -selective substrate with blood-brain barrier permeability that inhibits tumor growth.
- GC79577PFKFB4-IN-1CAS: 2664831-55-2Purity: >99.50%
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels.
- GC79584UDP-GlucosamineCAS: 17479-04-8Purity: >98%
UDP-Glucosamine is a sugar nucleotide analog, glycosyl donor, and metabolite of D-galactosamine.
- GC79816CryptolepineCAS: 480-26-2Purity: >98%
Cryptolepine is an orally active multi-potent alkaloid with anti-cancer, anti-bacterial, anti-viral, anti-malarial, anti-inflammatory, anti-hyperglycemic, relieve pain and other properties.
- GC79867Prexasertib-d 4Purity: >98.00%
Prexasertib -d 4 (LY2606368-d 4 ) is the deuterium labeled Prexasertib.
- GC79871CHNQD-00824CAS: 2222643-74-3Purity: >98%
CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect.
- GC79989Irinotecan- 13 C 6CAS: 718613-65-1Purity: >98%
Irinotecan - 13 C 6 ((+)-Irinotecan- 13 C 6 ) is the 13 C-labeled Irinotecan.
- GC79990Gemcitabine- 13 C, 15 N 2CAS: 1233921-74-8Purity: >99.00%
antimetabolite and an antineoplastic agent.
- GC79991Im-m7GDP sodiumCAS: 240137-51-3Purity: >89.00%
Im-m7GDP sodium is a capping reagent and also the P-imidazolide of N7-methylguanosine 5'-diphosphate.
- GC80333Ac-QPKK(Ac)-AMC acetatePurity: >99.00%
Ac-QPKK(Ac)-AMC acetate is a p53-derived peptide conjugated with a fluorophore, which serves as a fluorescent peptide substrate for detecting the deacylase activity of zinc-dependent HDACs and sirtuins (Ex = 360 nm; Em = 460 nm) [1] .
- GC80334Rucaparib-d 3CAS: 2271225-13-7Purity: >98.00%
Rucaparib -d 3 (AG014699-d 3 ) is the deuterated -labeled Rucaparib.
- GC80477Sodium butyrate-d 3CAS: 347840-05-5Purity: >99.50%
Sodium butyrate -d 3 (Butanoic acid-d 3 sodium) is the deuterium labeled Sodium butyrate.
- GC80850Gartisertib-d 8CAS: 1792214-00-6Purity: >98%
Gartisertib -d 8 (VX-803-d 8 ) is the deuterium labeled Gartisertib.
- GC80875PROTAC survivin degrader-1CAS: 3079079-69-6Purity: >98%
PROTAC survivin degrader-1 is an orally active, CNS-penetrant survivin -targeting PROTAC.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79176 | ARUK2010489 | - | >96.50% | |
ARUK2010489 (Compound 23) is a potent, selective and brain-penetrant NUAK1 inhibitor with a pIC 50 of 8.7. | ||||
| GC79354 | YL0441 | - | >98.50% | |
YL0441 is an inhibitor of ΔFOSB/JUND heterodimers and ΔFOSB homomultimers, with IC 50 values of 13.7 μM and 12.3 μM, respectively. | ||||
| GC79370 | PD-L1/HDAC6-IN-1 TFA | - | >99.50% | |
PD-L1/HDAC6-IN-1 TFA is an orally active dual inhibitor of PD-L1 and HDAC6, with IC 50 values of 26.8 nM and 78 nM, respectively. | ||||
| GC79451 | JP-11646 | 1902983-63-4 | >98.50% | |
JP-11646 is a pan-PIM inhibitor with increased potency against PIM2 ( IC 50 = 0.5 nM). | ||||
| GC79476 | ETC-501 | 3094990-88-9 | >97.00% | |
ETC-501 is a blood-brain barrier-permeable, orally active, and selective MNK1 / MNK2 inhibitor, with an IC 50 of 0.033 μM against MNK1 and 0.111 μM against MNK2. | ||||
| GC79488 | QBS10072S dihydrochloride | 1802735-31-4 | >98% | |
QBS10072S dihydrochloride is a LAT1 -selective substrate with blood-brain barrier permeability that inhibits tumor growth. | ||||
| GC79577 | PFKFB4-IN-1 | 2664831-55-2 | >99.50% | |
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels. | ||||
| GC79584 | UDP-Glucosamine | 17479-04-8 | >98% | |
UDP-Glucosamine is a sugar nucleotide analog, glycosyl donor, and metabolite of D-galactosamine. | ||||
| GC79816 | Cryptolepine | 480-26-2 | >98% | |
Cryptolepine is an orally active multi-potent alkaloid with anti-cancer, anti-bacterial, anti-viral, anti-malarial, anti-inflammatory, anti-hyperglycemic, relieve pain and other properties. | ||||
| GC79866 | Gem-C12 | 849139-19-1 | >99.00% | |
Gem-C12 is a prodrug of Gemcitabine. | ||||
| GC79867 | Prexasertib-d 4 | - | >98.00% | |
Prexasertib -d 4 (LY2606368-d 4 ) is the deuterium labeled Prexasertib. | ||||
| GC79871 | CHNQD-00824 | 2222643-74-3 | >98% | |
CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect. | ||||
| GC79988 | GS-441524-d | 2647440-98-8 | >98% | |
GS-441524 -d is the deuterium labeled GS-441524. | ||||
| GC79989 | Irinotecan- 13 C 6 | 718613-65-1 | >98% | |
Irinotecan - 13 C 6 ((+)-Irinotecan- 13 C 6 ) is the 13 C-labeled Irinotecan. | ||||
| GC79990 | Gemcitabine- 13 C, 15 N 2 | 1233921-74-8 | >99.00% | |
antimetabolite and an antineoplastic agent. | ||||
| GC79991 | Im-m7GDP sodium | 240137-51-3 | >89.00% | |
Im-m7GDP sodium is a capping reagent and also the P-imidazolide of N7-methylguanosine 5'-diphosphate. | ||||
| GC79992 | TK216-d 4 | 3034816-36-6 | >98.50% | |
TK216 -d 4 is the deuterium labeled TK216. | ||||
| GC80333 | Ac-QPKK(Ac)-AMC acetate | - | >99.00% | |
Ac-QPKK(Ac)-AMC acetate is a p53-derived peptide conjugated with a fluorophore, which serves as a fluorescent peptide substrate for detecting the deacylase activity of zinc-dependent HDACs and sirtuins (Ex = 360 nm; Em = 460 nm) [1] . | ||||
| GC80334 | Rucaparib-d 3 | 2271225-13-7 | >98.00% | |
Rucaparib -d 3 (AG014699-d 3 ) is the deuterated -labeled Rucaparib. | ||||
| GC80477 | Sodium butyrate-d 3 | 347840-05-5 | >99.50% | |
Sodium butyrate -d 3 (Butanoic acid-d 3 sodium) is the deuterium labeled Sodium butyrate. | ||||
| GC80850 | Gartisertib-d 8 | 1792214-00-6 | >98% | |
Gartisertib -d 8 (VX-803-d 8 ) is the deuterium labeled Gartisertib. | ||||
| GC80875 | PROTAC survivin degrader-1 | 3079079-69-6 | >98% | |
PROTAC survivin degrader-1 is an orally active, CNS-penetrant survivin -targeting PROTAC. | ||||
| GC80882 | ZLY025 | 3070379-34-6 | >99.00% | |
ZLY025 is a potent and orally active CCNK molecular glue degrader with an DC 50 of 42.7 nM. | ||||
| GC80884 | CXJ2080 | - | >98% | |
CXJ2080 is a selective PROTAC-based CDK7 degrader with a DC 50 of 0.88 nM. | ||||
